10/02/2016 03:46:31 1-888-992-3836 (toll free) Free Membership Login

Biota Pharmaceuticals News (NASDAQ:BOTA)

DateTimeSource
Headline
02/08/20167:00AMGLOBEBiota Commences Dosing in Phase 2 Trial of Antiviral Therapy BTA074 for Topical Treatment of Condyloma
ATLANTA, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that the first patient has been dosed in a Phase 2 double-blind... More...>>
02/05/20167:00AMGLOBEBiota Pharmaceuticals Reports Second Quarter Fiscal Year 2016 Financial Results
ATLANTA, Feb. 05, 2016 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) today announced its financial results for the three month period ended December 31, 2015, which is the second quarter of the Company's 2016 fiscal year, and also provided an update on recent corporate developments. “I am very pleased... More...>>
01/29/20169:00AMGLOBEBiota Pharmaceuticals to Host Conference Call to Report Second Quarter Fiscal Year 2016 Financial Results on February 5, 2016...
ATLANTA, Jan. 29, 2016 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the “Company”), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that management will host a conference... More...>>
12/18/20157:00AMGLOBEBiota Announces Positive Phase 1 Data for Direct-Acting RSV Antiviral BTA585 
ATLANTA, Dec. 18, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that it completed an initial Phase 1 single ascending dose... More...>>
12/11/20154:01PMGLOBEBiota Pharmaceuticals to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference
ATLANTA, Dec. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that Biota's executive team will participate in the Guggenheim... More...>>
11/11/20154:01PMGLOBEBiota Pharmaceuticals to Present at Stifel 2015 Healthcare Conference
ATLANTA, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that Biota's CEO & President Joseph Patti... More...>>
11/06/20157:00AMGLOBEBiota Pharmaceuticals Reports First Quarter Fiscal Year 2016 Financial Results
ATLANTA, Nov. 6, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options, today announced its financial results for the three month period ended September... More...>>
11/02/20157:00AMGLOBEBiota Pharmaceuticals Announces Appointment of Mark P. Colonnese as Chief Financial Officer
ATLANTA, Nov. 2, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today the appointment of Mark P. Colonnese as Executive Vice President... More...>>
10/30/20159:00AMGLOBEBiota Pharmaceuticals to Host Conference Call to Report First Quarter Fiscal Year 2016 Financial Results on November 6, 2015
ATLANTA, Oct. 30, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that management will host a conference call... More...>>
10/09/20158:31PMBWBIOTA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation of Biota Pharmaceuticals, Inc.; Invest...
Shareholder rights law firm Johnson & Weaver, LLP continues its investigation into whether certain officers and directors of Biota Pharmaceuticals, Inc, (Nasdaq: BOTA) violated state or federal laws. Biota Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of anti-infective... More...>>
09/22/20154:15PMGLOBEBiota Pharmaceuticals to Present at Ladenburg Thalmann 2015 Healthcare Conference
ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals that address infections that have limited therapeutic options, announced today that Biota's CEO & President Joseph Patti... More...>>
09/22/20157:00AMGLOBEBiota Pharmaceuticals Appoints Armando Anido and Michael Dunne, M.D. to Its Board of Directors
ATLANTA, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options, today announced the appointments of Armando Anido and Michael... More...>>
09/21/20158:46PMGLOBEBiota Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results
ATLANTA, Sept. 11, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals to treat infections that have limited therapeutic options, today announced its financial results for the fourth quarter... More...>>
05/07/20157:00AMGLOBEBiota Pharmaceuticals Reports Third Quarter Fiscal Year 2015 Financial Results
ATLANTA, May 7, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening viral respiratory infectious diseases, today announced its financial results... More...>>
04/30/20154:01PMGLOBEBiota Pharmaceuticals to Host Conference Call to Report Third Quarter Fiscal Year 2015 Financial Results
ATLANTA, April 30, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening viral respiratory infectious diseases, announced today that it will host a conference call... More...>>
03/03/20155:27PMGLOBEBiota Pharmaceuticals to Present at the 27th Annual Roth Conference
ATLANTA, March 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening viral respiratory infectious diseases, announced today that Biota CEO &... More...>>
03/03/20157:00AMGLOBEBiota Commences Dosing in Vapendavir SPIRITUS Phase 2b Trial
ATLANTA, March 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) announced today that it has commenced dosing of patients in its Phase 2b SPIRITUS trial of vapendavir. The goal of the study is to enroll approximately 150 laboratory-confirmed human rhinovirus (HRV) infected patients with moderate-to-severe... More...>>
02/26/20157:00AMGLOBEBiota Pharmaceuticals to Acquire Anaconda Pharma
Phase 2 Antiviral for the Treatment of Diseases Caused by Human Papillomavirus Strengthens Pipeline Conference Call Today at 9:00 A.M. EST ATLANTA, Feb. 26, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals (Nasdaq:BOTA) (the "Company") announced today that it has entered into a definitive agreement to acquire Anaconda Pharma... More...>>
02/05/20157:00AMGLOBEBiota Pharmaceuticals Reports Second Quarter Fiscal Year 2015 Financial Results
ATLANTA, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company") today announced its financial results for the three month period ended December 31, 2014, which is the second quarter of the Company's 2015 fiscal year, and also provided an update on recent corporate developments. "We are... More...>>
02/03/20153:00PMGLOBEBiota Pharmaceuticals to Present at the 2015 BIO CEO & Investor Conference
ATLANTA, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening viral respiratory infectious diseases, announced today that Biota CEO &... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V:us D:20160210 08:46:33